English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Glycomic and sialoproteomic data of gastric carcinoma cells overexpressing ST3GAL4

MPS-Authors
/persons/resource/persons188000

Almeida,  Andreia
Daniel Kolarich, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121498

Kolarich,  Daniel
Daniel Kolarich, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

2260479.pdf
(Publisher version), 5MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Mereiter, S., Magalhães, A., Adamczyk, B., Jin, C., Almeida, A., Drici, L., et al. (2016). Glycomic and sialoproteomic data of gastric carcinoma cells overexpressing ST3GAL4. Data in Brief, 7, 814-833. doi:10.1016/j.dib.2016.03.022.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002A-22D1-8
Abstract
Gastric carcinoma MKN45 cells stably transfected with the full-length ST3GAL4 gene were characterised by glycomic and sialoproteomic analysis. Complementary strategies were applied to assess the glycomic alterations induced by ST3GAL4 overexpression. The N-and O-glycome data were generated in two parallel structural analyzes, based on PGC-ESI-MS/MS. Data on glycan structure identification and relative abundance in ST3GAL4 overexpressing cells and respective mock control are presented. The sialoproteomic analysis based on titanium-dioxide enrichment of sialopeptides with subsequent LC-MS/MS identification was performed. This analysis identified 47 proteins with significantly increased sialylation. The data in this article is associated with the research article published in Biochim Biophys Acta “Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer” [1].